ATE219099T1 - Verfahren zur identifizierung von verbindungen, die zur behandlung von autoimmunkrankheiten verwendbar sind - Google Patents

Verfahren zur identifizierung von verbindungen, die zur behandlung von autoimmunkrankheiten verwendbar sind

Info

Publication number
ATE219099T1
ATE219099T1 AT95930911T AT95930911T ATE219099T1 AT E219099 T1 ATE219099 T1 AT E219099T1 AT 95930911 T AT95930911 T AT 95930911T AT 95930911 T AT95930911 T AT 95930911T AT E219099 T1 ATE219099 T1 AT E219099T1
Authority
AT
Austria
Prior art keywords
identifying compounds
ciita
activation
autoimmune diseases
methods
Prior art date
Application number
AT95930911T
Other languages
English (en)
Inventor
Laurie H Glimcher
Hong Zhou
John Douhan Iii
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of ATE219099T1 publication Critical patent/ATE219099T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT95930911T 1994-08-24 1995-08-22 Verfahren zur identifizierung von verbindungen, die zur behandlung von autoimmunkrankheiten verwendbar sind ATE219099T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/295,502 US5672473A (en) 1994-08-24 1994-08-24 Methods of identifying compounds useful for treating autoimmune diseases
PCT/US1995/010691 WO1996006107A1 (en) 1994-08-24 1995-08-22 Methods of identifying compounds useful for treating autoimmune diseases

Publications (1)

Publication Number Publication Date
ATE219099T1 true ATE219099T1 (de) 2002-06-15

Family

ID=23137979

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95930911T ATE219099T1 (de) 1994-08-24 1995-08-22 Verfahren zur identifizierung von verbindungen, die zur behandlung von autoimmunkrankheiten verwendbar sind

Country Status (18)

Country Link
US (1) US5672473A (de)
EP (1) EP0777677B1 (de)
JP (1) JPH10507908A (de)
KR (1) KR970705573A (de)
AT (1) ATE219099T1 (de)
AU (1) AU700235B2 (de)
CA (1) CA2197233C (de)
DE (1) DE69527073T2 (de)
ES (1) ES2178677T3 (de)
FI (1) FI970735L (de)
MX (1) MX9701295A (de)
NO (1) NO970803L (de)
NZ (1) NZ292369A (de)
PL (1) PL318812A1 (de)
PT (1) PT777677E (de)
RU (1) RU2160447C2 (de)
WO (1) WO1996006107A1 (de)
ZA (1) ZA957120B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994082A (en) * 1994-08-26 1999-11-30 Mach; Bernard Methods for the identification of inhibitors which suppress the activity of proteins displaying CIITA activity
US20020155542A1 (en) * 1994-08-26 2002-10-24 Mach Bernard F. Inhibitors for suppressing the activity of proteins displaying CIITA activity, methods for their identification and pharmaceutical compositions
US5994505A (en) * 1996-12-11 1999-11-30 The University Of North Carolina At Chapel Hill Forms of class II MHC transactivator (CIITA)
US6426411B1 (en) * 1997-05-30 2002-07-30 Dana-Farber Cancer Institute PGC-1, a novel brown fat pparγ coactivator
US6410261B2 (en) 1997-11-06 2002-06-25 President And Fellows Of Harvard College CIITA-interacting proteins and methods of use therefor
FR2775003A1 (fr) 1998-02-19 1999-08-20 Transgene Sa Methode de criblage de composes capables d'inhiber la fixation entre le facteur de transcription stat1 et le facteur de transcription usf1
AU4219899A (en) 1998-05-28 1999-12-13 President And Fellows Of Harvard College Methods and compositions relating to modulation of cartilage cell growth and/or differentiation by modulation of nfatp activity
US20050244849A1 (en) * 2000-12-15 2005-11-03 Genetics Institute, Llc Screening assays for rheumatoid arthritis
US20030125273A1 (en) * 2001-12-05 2003-07-03 Isis Pharmaceuticals Inc, Antisense modulation of MHC class II transactivator expression
WO2005049860A2 (en) * 2003-11-05 2005-06-02 Karolinska Innovations Ab Diagnostic and therapeutic methods and assays

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130297A (en) * 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
PT648836E (pt) * 1993-08-26 2002-06-28 Novimmune Sa Transactivador do mhc de classe ii (ciita) e suas utilizacoes

Also Published As

Publication number Publication date
FI970735A7 (fi) 1997-04-21
PT777677E (pt) 2002-11-29
WO1996006107A1 (en) 1996-02-29
EP0777677B1 (de) 2002-06-12
DE69527073D1 (de) 2002-07-18
US5672473A (en) 1997-09-30
PL318812A1 (en) 1997-07-07
EP0777677A4 (de) 1998-04-01
CA2197233A1 (en) 1996-02-29
AU700235B2 (en) 1998-12-24
MX9701295A (es) 1997-05-31
RU2160447C2 (ru) 2000-12-10
EP0777677A1 (de) 1997-06-11
ES2178677T3 (es) 2003-01-01
NO970803L (no) 1997-04-21
KR970705573A (ko) 1997-10-09
FI970735L (fi) 1997-04-21
DE69527073T2 (de) 2003-01-23
FI970735A0 (fi) 1997-02-21
NZ292369A (en) 1999-01-28
CA2197233C (en) 2001-02-20
AU3412695A (en) 1996-03-14
JPH10507908A (ja) 1998-08-04
ZA957120B (en) 1996-03-26
NO970803D0 (no) 1997-02-21

Similar Documents

Publication Publication Date Title
ATE197479T1 (de) Verfahren zur vervielfältigung von nukleinsäuresequenzen
DE69710077D1 (de) Verfahren zur erkennung von verbindungen, die die interaktion von rna und rna-bindeproteinen beeinflussen
DE69712901D1 (de) Verfahren zur übertragung von rechnernetzdaten als teil des vertikalen austastintervalls
DE69603838D1 (de) Verfahren zur behandlung von gasen
DE69427144D1 (de) Verfahren und System zur Herstellung von Ethanol aus Mikroalgen
ATE152748T1 (de) Verfahren zur herstellung von siloxanoxyalkylencopolymeren
DE60027732D1 (de) Verwendung von anti-rubeola antkörpern zur behandlung von symptomen von erkrankungen des zentralen nervensystems
DE69636156D1 (de) Verfahren und Einrichtung zur Ausgleichung von Stromquellen
DE69734934D1 (de) Verfahren und vorrichtung zur projektion von schallquellen auf lautsprechern
EP0632894A4 (de) Verfahren zur erzeugung homogener reagenzien.
ATE219099T1 (de) Verfahren zur identifizierung von verbindungen, die zur behandlung von autoimmunkrankheiten verwendbar sind
DE69605902D1 (de) Verfahren zur stabilisierung von schlamm
ATE270275T1 (de) Verfahren zur herstellung von 2-aryl-3-aryl-5- halogen-pyridinen, verwendbar als cox-2 inhibitoren
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
DE59102745D1 (de) Verfahren une einrichtung zur behandlung von saatgut.
ATE213163T1 (de) Verfahren zur behandlung von motorischen defiziten
DE69622689D1 (de) System,vorrichtung und verfahren zur aufnahme und wiedergabe von informationen
DE58904756D1 (de) Verfahren zur herstellung von tert.-amylalkohol (taa).
ATE278702T1 (de) Verfahren zur synthese von phosphorothioat- oligonukelotiden
DE3779287D1 (de) Verfahren zur reinigung von tryptophan.
ATE189804T1 (de) Selektives verfahren zur deacylierung von acylverbindungen
DE59006773D1 (de) Verfahren zur Bereitstellung von elektrischen Informationsgrössen.
ATE506075T1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
DE59603661D1 (de) Verfahren zur Herstellung von Polyisoolefinen mittels neuer Initiatorsysteme
DE69516610D1 (de) Verfahren zur Redistribution von Polycarbonat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties